Trademarkia Logo

Canada

C$
STAR AND HEART DESIGN
REGISTERED

on 18 Oct 2024

Last Applicant/ Owned by

LEXOGEN GMBH

Campus-Vienna-Biocenter 5,Helmut-Qualtinger-Gasse 6A-1030 Wien

AT

Serial Number

2154456 filed on 30th Sept 2021

Registration Number

TMA1263952 registered on 18th Oct 2024

Registration expiry Date

30th Sept 2031

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

CA

K1P5Y6

STAR AND HEART DESIGN

Trademark usage description

chemical and biochemical products for biotechnological purposes, namely, chemical and biochemical substances for molecular biological use, namely, for Read More

Vienna Information


2 . 9 . 1

Hearts -- Note: Including also hearts represented as a symbol or on playing cards.Coeurs -- Note: Y compris les coeurs représentés comme symboles ou figurant sur des jeux de cartes.

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

1 . 1 . 1

StarsÉtoiles

1 . 1 . 2

One starUne étoile

1 . 1 . 10

Stars with more than four pointsÉtoiles à plus de quatre pointes

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

Classification Information


Class [001]
Chemical and biochemical products for biotechnological purposes, namely, chemical and biochemical substances for molecular biological use, namely, for use in the isolation, purification, modification and extraction of DNA and RNA, and rRNA depletion kits containing buffers and chemical reagents for molecular biological use; chemical reagents for scientific purposes for purifying and analyzing samples for use in the fields of molecular biology, chemistry, biochemistry, drug discovery, pharmacology, toxicology, molecular pathology, disease research, genomics and proteomics; chemical, biochemical and biotechnological substances for industrial and scientific purposes, namely, polypeptides and proteins for use in connection with molecular biological applications for DNA (deoxyribonucleic acid) treatment, RNA (ribonucleic acid) treatment and protein treatment; chemical, biochemical and biotechnological preparations for diagnostic and scientific purposes, laboratory reagents for scientific use and diagnostic reagents for clinical or medical laboratory use, all the aforesaid goods, in particular for the treatment and purification of samples of human, animal and plant cells and tissues and samples of microorganisms and of extracts therefrom for industrial and scientific purposes; diagnostic reagents for in vitro use in clinical chemistry; enzymes, other than for medical and veterinary purposes, namely, for use in test kits for laboratory research and for use in carrying out DNA labeling, DNA replication, DNA analysis or RNA labeling, RNA replication, RNA analysis and for enzyme preparations for RNA treatment.


Classification kind code

11

Class [005]
Veterinary products, namely, veterinary diagnostic reagents; pharmaceutical preparations, namely, nucleic acid sequences and proteins used for medical and veterinary purposes, for use in determining genotypes, profiling biopolymer, detecting disease, determining disease progression, and determining responses to drugs; diagnostic reagents for medical use in diagnosing inflammation, infection, central nervous system diseases, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, and cancer, comprised of reagents, processing chemicals and nucleic acid molecules; medical diagnostic test kits composed of medical diagnostic reagents for the detection of pathogens in the environment; clinical and diagnostic reagents and preparations for medical and veterinary purposes; medical diagnostic test kits composed of medical diagnostic reagents to identify, quantify and analyze dna and rna; reagents and enzymes for performing dna or rna analyzes for medical purposes.


Classification kind code

11

Class [009]
Scientific apparatus, instruments and devices, namely, magnetic cell separators and single cell handling devices for research and diagnostic purposes; software, namely, software for data analysis in the field of RNA and DNA analysis, namely, for Next Generation Sequencing data analysis, software for the analysis of bioinformatic data, sequence data on fragmented sequence information, for pcr analysis and for next generation sequencing; chromatographic columns for scientific or laboratory use; all the aforesaid goods for industrial and scientific purposes, in particular for molecular biological purposes for DNA (deoxyribonucleic acid) treatment, RNA (ribonucleic acid) treatment and protein treatment or for the purification of these molecules, and for reagent kits for industrial and scientific purposes, in particular for DNA (deoxyribonucleic acid) treatment, RNA (ribonucleic acid) treatment and protein treatment or purification of these molecules; laboratory equipment, in particular automated microfluidic and macrofluidic devices, namely, magnetic cell separators and single cell handling devices for the isolation, preparation, marking, replication or screening of genetic material or RNA or proteins.


Classification kind code

11

Class [042]
Scientific research and development, namely, in the field of molecular biology, genetics and diseases research, development and diagnostics; product and computer software design services in the field of molecular biology, genetics and diseases research, development and diagnostics; scientific and technological services, namely scientific analysis in the field of research, development and diagnostics relating to genomics, transcriptomics, proteomics and genetic engineering; design of pharmaceutical and medical diagnostic products and biochemical and biotechnological preparations relating to genomics, transcriptomics, proteomics and genetic engineering; scientific and technological services, namely scientific research, development, diagnostics and analysis in the field of diagnostic chemicals and reagents, sorting of nucleotides, separation processes and purification processes, chemical screening analyzes and conducting diagnostic, forensic and genetic-medical tests for others; scientific research and development for others in the field of diagnostic chemical agents and reagents for use as diagnostic, therapeutic preparations and chemical screening and diagnostics for others; conducting quality control tests and quality control of scientific analyzes relating to nucleic acids; scientific analyzes in relation to nucleic acids, in particular for detection purposes; scientific and technological services, in particular scientific and technological services for the treatment of nucleic acids and proteins, in particular separation, purification, isolation, labeling and amplification of the aforesaid molecules; development of computer software for data analysis for the analysis of bioinformatic data, sequence data and fragmented sequence information, and development of software for pcr analysis and next generation sequencing; scientific analyzes of bioinformatic data, sequence data and fragmented sequence information, especially in the context of next generation sequencing.


Classification kind code

11

Mark Details


Serial Number

2154456

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 14th Jul 2023
Agent Changed
Submitted for opposition 22
on 14th Apr 2023
Search Recorded
Submitted for opposition 20
on 14th Apr 2023
Examiner's First Report
Submitted for opposition 223
on 14th Apr 2023
Total Provisional Refusal
Submitted for opposition 256
on 17th Oct 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 16th Dec 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 15th Dec 2021
Formalized
Submitted for opposition 1
on 15th Dec 2021
Created
Submitted for opposition 228
on 30th Sept 2021
International Registration
Submitted for opposition 30
on 30th Sept 2021
Filed